Experimental  	Experimental  	 JJ	B-NP
strategies  	strategies  	 NNS	I-NP
in  	in  	 IN	O
gene  	gene  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
Gene  	Gene  	 NNP	I-NP
therapy  	therapy  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
new  	new  	 JJ	O
and  	and  	 CC	O
innovative  	innovative  	 JJ	B-NP
approach  	approach  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
malignant  	malignant  	 JJ	O
neoplasms 	neoplasms 	 NN	O
,  	,  	 ,	O
although  	although  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
still  	still  	 RB	O
not  	not  	 RB	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
eradicating  	eradicating  	 JJ	O
cancer  	cancer  	 NN	O
in  	in  	 IN	O
humans 	humans 	 NNS	O
.  	.  	 .	O
Selection  	Selection  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
appropriate  	appropriate  	 JJ	O
vector  	vector  	 NN	B-NP
with  	with  	 IN	O
maximal  	maximal  	 JJ	B-NP
efficiency  	efficiency  	 NN	I-NP
and  	and  	 CC	O
minimal  	minimal  	 JJ	O
toxicity  	toxicity  	 NN	O
is  	is  	 VBZ	O
crucial  	crucial  	 JJ	O
for  	for  	 IN	O
gene  	gene  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
and  	and  	 CC	O
numerous  	numerous  	 JJ	B-NP
viral  	viral  	 NN	I-NP
and  	and  	 CC	O
non-viral  	non-viral  	 JJ	B-NP
( 	( 	 -LRB-	O
synthetic 	synthetic 	 LS	B-NP
)  	)  	 -RRB-	O
methods  	methods  	 NNS	O
for  	for  	 IN	O
gene  	gene  	 NN	B-NP
transfer  	transfer  	 NN	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
developed 	developed 	 VBN	O
.  	.  	 .	O
There  	There  	 EX	O
are  	are  	 VBP	O
different  	different  	 JJ	O
gene  	gene  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
approaches  	approaches  	 NNS	I-NP
for  	for  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
treatment  	treatment  	 NN	I-NP
such  	such  	 JJ	O
as 	as 	 IN	O
:  	:  	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
gene  	gene  	 NN	B-NP
correction 	correction 	 NN	I-NP
;  	;  	 :	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
molecular  	molecular  	 JJ	B-NP
chemotherapy 	chemotherapy 	 NN	I-NP
;  	;  	 :	O
3 	3 	 LS	O
)  	)  	 -RRB-	O
proapoptotic  	proapoptotic  	 JJ	B-NP
gene  	gene  	 NN	I-NP
therapy 	therapy 	 NN	I-NP
;  	;  	 :	O
4 	4 	 LS	O
)  	)  	 -RRB-	O
antiangiogenic  	antiangiogenic  	 JJ	B-NP
gene  	gene  	 NN	I-NP
therapy 	therapy 	 NN	I-NP
;  	;  	 :	O
5 	5 	 LS	O
)  	)  	 -RRB-	O
immune  	immune  	 JJ	O
gene  	gene  	 NN	B-NP
therapy 	therapy 	 NN	I-NP
;  	;  	 :	O
and  	and  	 CC	O
6 	6 	 CD	O
)  	)  	 -RRB-	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	I-NP
drug  	drug  	 NN	I-NP
resistance 	resistance 	 NN	I-NP
/ 	/ 	 CD	I-NP
sensitivity 	sensitivity 	 NN	I-NP
.  	.  	 .	O
Cancer  	Cancer  	 NN	B-NP
gene  	gene  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
represents  	represents  	 VBZ	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
rapidly  	rapidly  	 RB	O
developing  	developing  	 VBG	B-NP
areas  	areas  	 NNS	I-NP
in  	in  	 IN	O
preclinical  	preclinical  	 NN	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
research 	research 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
some  	some  	 DT	O
problems  	problems  	 NNS	O
need  	need  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
solved  	solved  	 VBN	O
to  	to  	 TO	O
make  	make  	 VB	O
sure  	sure  	 RB	O
this  	this  	 DT	O
strategy  	strategy  	 NN	O
is  	is  	 VBZ	O
safe 	safe 	 JJ	O
,  	,  	 ,	O
effective  	effective  	 JJ	O
and  	and  	 CC	O
long-lasting  	long-lasting  	 JJ	O
before  	before  	 IN	O
it  	it  	 PRP	O
becomes  	becomes  	 VBZ	O
routinely  	routinely  	 RB	O
adopted  	adopted  	 VBN	O
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
practice 	practice 	 NN	I-NP
.  	.  	 .	O
